Policy & Regulation by the Numbers: The 2026 Data Brief
The verified statistics that define policy & regulation in 2026, with sources.
Numbers cut through narrative. These are the verified data points our research desk considers most decision-relevant in policy & regulation right now - each drawn from primary sources and our own reporting.
The numbers
1. CMS launched a dedicated Office of Health Technology Products to steer AI and interoperability policy (our coverage).
2. The FDA-CMS TEMPO pilot ties regulatory evaluation to real-world outcomes and Medicare coverage, with Dexcom as its first participant (our coverage).
3. The proposed CY2027 fee schedule would create Medicare's first payment category for clinical AI software (our coverage).
4. Eleven states have enacted twenty laws governing AI in mental health, from outright bans to crisis-routing mandates (our coverage).
How to read them
Individually, each figure is a snapshot. Together they describe a category where capital is concentrating, regulation is catching up, and proof is displacing promise. When these numbers move, strategy should move with them - which is why each links to the underlying coverage.
For continuously updated developments, follow Policy & Regulation and its topic feeds.